Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7,851 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Structural basis of receptor recognition by SARS-CoV-2.
Shang J, Ye G, Shi K, Wan Y, Luo C, Aihara H, Geng Q, Auerbach A, Li F. Shang J, et al. Among authors: wan y. Nature. 2020 May;581(7807):221-224. doi: 10.1038/s41586-020-2179-y. Epub 2020 Mar 30. Nature. 2020. PMID: 32225175 Free PMC article.
Lysosomal Proteases Are a Determinant of Coronavirus Tropism.
Zheng Y, Shang J, Yang Y, Liu C, Wan Y, Geng Q, Wang M, Baric R, Li F. Zheng Y, et al. Among authors: wan y. J Virol. 2018 Nov 27;92(24):e01504-18. doi: 10.1128/JVI.01504-18. Print 2018 Dec 15. J Virol. 2018. PMID: 30258004 Free PMC article.
Cell entry mechanisms of SARS-CoV-2.
Shang J, Wan Y, Luo C, Ye G, Geng Q, Auerbach A, Li F. Shang J, et al. Among authors: wan y. Proc Natl Acad Sci U S A. 2020 May 26;117(21):11727-11734. doi: 10.1073/pnas.2003138117. Epub 2020 May 6. Proc Natl Acad Sci U S A. 2020. PMID: 32376634 Free PMC article.
The Development of a Novel Nanobody Therapeutic for SARS-CoV-2.
Ye G, Gallant JP, Massey C, Shi K, Tai W, Zheng J, Odle AE, Vickers MA, Shang J, Wan Y, Drelich A, Kempaiah KR, Tat V, Perlman S, Du L, Tseng CT, Aihara H, LeBeau AM, Li F. Ye G, et al. Among authors: wan y. bioRxiv [Preprint]. 2020 Nov 17:2020.11.17.386532. doi: 10.1101/2020.11.17.386532. bioRxiv. 2020. Update in: Elife. 2021 Aug 02;10:e64815. doi: 10.7554/eLife.64815. PMID: 33236012 Free PMC article. Updated. Preprint.
The development of Nanosota-1 as anti-SARS-CoV-2 nanobody drug candidates.
Ye G, Gallant J, Zheng J, Massey C, Shi K, Tai W, Odle A, Vickers M, Shang J, Wan Y, Du L, Aihara H, Perlman S, LeBeau A, Li F. Ye G, et al. Among authors: wan y. Elife. 2021 Aug 2;10:e64815. doi: 10.7554/eLife.64815. Elife. 2021. PMID: 34338634 Free PMC article.
Novel virus-like nanoparticle vaccine effectively protects animal model from SARS-CoV-2 infection.
Geng Q, Tai W, Baxter VK, Shi J, Wan Y, Zhang X, Montgomery SA, Taft-Benz SA, Anderson EJ, Knight AC, Dinnon KH 3rd, Leist SR, Baric RS, Shang J, Hong SW, Drelich A, Tseng CK, Jenkins M, Heise M, Du L, Li F. Geng Q, et al. Among authors: wan y. PLoS Pathog. 2021 Sep 7;17(9):e1009897. doi: 10.1371/journal.ppat.1009897. eCollection 2021 Sep. PLoS Pathog. 2021. PMID: 34492082 Free PMC article.
7,851 results